Technical Analysis for PRME - Prime Medicine, Inc.
| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Weak or Absent | N/A | Down | Up |
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| Fell Below 50 DMA | Bearish | 1.65% | |
| 20 DMA Support | Bullish | 1.65% | |
| 20 DMA Support | Bullish | -1.15% | |
| Crossed Above 50 DMA | Bullish | -1.15% | |
| Up 3 Days in a Row | Strength | -1.15% | |
| Up 4 Days in a Row | Strength | -1.15% | |
| Up 5 Days in a Row | Strength | -1.15% | |
| Crossed Above 20 DMA | Bullish | 0.17% | |
| Up 3 Days in a Row | Strength | 0.17% | |
| Up 4 Days in a Row | Strength | 0.17% |
Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App
| Alert | Time |
|---|---|
| 50 DMA Resistance | about 2 hours ago |
| 60 Minute Opening Range Breakout | about 2 hours ago |
| Rose Above Previous Day's High | about 2 hours ago |
| Rose Above Upper Bollinger Band | about 2 hours ago |
| Rose Above 50 DMA | about 2 hours ago |
Get a Trading Assistant
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: ???
Prime Medicine is a biotechnology company committed to delivering a new class of differentiated, one-time, curative genetic therapies to address the widest spectrum of diseases. The company is deploying Prime Editing technology, a versatile, precise, efficient and broad gene editing technology, which is designed to make only the right edit at the right position within a gene. With the theoretical potential to repair approximately 90 percent of known disease-causing genetic mutations across many organs and cell types, medicines based on Prime Editing, if approved, could offer a one-time curative genetic therapeutic option to a broad set of patients.
Sector: Healthcare
Industry: Biotechnology
Keywords: Biotechnology Life Sciences Disease Emerging Technologies Molecular Biology Medical Genetics Genetic Engineering Gene Editing Technology
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Biotechnology Life Sciences Disease Emerging Technologies Molecular Biology Medical Genetics Genetic Engineering Gene Editing Technology
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 21.7301 |
| 52 Week Low | 14.52 |
| Average Volume | 205,245 |
| 200-Day Moving Average | 0.00 |
| 50-Day Moving Average | 17.38 |
| 20-Day Moving Average | 16.85 |
| 10-Day Moving Average | 16.65 |
| Average True Range | 1.04 |
| RSI | 50.00 |
| ADX | 11.67 |
| +DI | 17.91 |
| -DI | 12.71 |
| Chandelier Exit (Long, 3 ATRs) | 17.01 |
| Chandelier Exit (Short, 3 ATRs) | 18.54 |
| Upper Bollinger Bands | 18.21 |
| Lower Bollinger Band | 15.49 |
| Percent B (%b) | 0.54 |
| BandWidth | 16.13 |
| MACD Line | -0.11 |
| MACD Signal Line | -0.22 |
| MACD Histogram | 0.1136 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 17.89 | ||||
| Resistance 3 (R3) | 17.94 | 17.68 | 17.74 | ||
| Resistance 2 (R2) | 17.68 | 17.45 | 17.66 | 17.69 | |
| Resistance 1 (R1) | 17.33 | 17.31 | 17.20 | 17.28 | 17.63 |
| Pivot Point | 17.07 | 17.07 | 17.01 | 17.05 | 17.07 |
| Support 1 (S1) | 16.71 | 16.84 | 16.59 | 16.66 | 16.31 |
| Support 2 (S2) | 16.46 | 16.69 | 16.43 | 16.25 | |
| Support 3 (S3) | 16.10 | 16.46 | 16.20 | ||
| Support 4 (S4) | 16.05 |
